Comments
Loading...
Creative Medical Tech (CELZ) Forecast
NewsEarningsCreative Medical Tech (CELZ) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCreative Medical Tech (NASDAQ:CELZ) Stock Quotes, Forecast and News Summary
Creative Medical Tech Stock (NASDAQ: CELZ) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Creative Medical Tech (CELZ) stock?
You can purchase shares of Creative Medical Tech (NASDAQ:CELZ) through any online brokerage.
Who are Creative Medical Tech (CELZ) competitors?
Other companies in Creative Medical Tech’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Palisade Bio (NASDAQ:PALI) and Portage Biotech (NASDAQ:PRTG).
What is the forecast, or price target, for Creative Medical Tech (CELZ) stock?
Creative Medical Tech has a consensus price target of $10.00.
What is the current price for Creative Medical Tech (CELZ)?
The stock price for Creative Medical Tech (NASDAQ: CELZ) is $2.5872 last updated November 21, 2024 at 12:11 PM EST.
Does Creative Medical Tech (CELZ) pay a dividend?
There are no upcoming dividends for Creative Medical Tech.
When is Creative Medical Tech (NASDAQ:CELZ) reporting earnings?
Creative Medical Tech’s Q3 earnings are confirmed for Friday, November 8, 2024.
Is Creative Medical Tech (CELZ) going to split?
There is no upcoming split for Creative Medical Tech.
What sector and industry does Creative Medical Tech (CELZ) operate in?
Creative Medical Tech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.